ORAGENICS INC — Director's Dealing 2022

Jun 24, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2022-06-23

Reporting Person: Sullivan Michael O'Keefe (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-23	Employee Stock Option (Right to Buy)	$0.2950	A	250000	Acquired	2032-06-23	Common Stock (250000)	Direct

Footnotes

F1: Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with interim service to the Company as Principal Executive Officer. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022.